Evidence map›Paper›PMID 35943010›Full record

ArticleArchives of Iranian medicine2022

Major Depressive Disorder in Iran: Epidemiology, Health Care Provision, Utilization, and Challenges.

Masoumeh Amin-Esmaeili, Behrang Shadloo, Afarin Rahimi-Movaghar, Seyed Mehdi Samimi Ardestani, Ahmad Hajebi, Shahab Khatibzadeh, Vandad Sharifi, Roya Samadi, Mohammad Taghi Yasamy, Mehran Zarghami and 2 more

Abstract read
In one paragraph

Article in Archives of Iranian medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Masoumeh Amin-EsmaeiliIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-3888-3254
Behrang ShadlooIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0003-1884-9371
Afarin Rahimi-MovagharIranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-5761-1668
Seyed Mehdi Samimi ArdestaniDepartments of Psychiatry, Imam Hossein Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0002-2355-9304
Ahmad HajebiResearch Center for Addiction & Risky Behaviors (ReCARB), Psychiatric Department, Iran University of Medical Sciences (IUMS), Tehran, Iran.ORCID 0000-0001-8435-0398
Shahab KhatibzadehThe Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.
Vandad SharifiDepartment of Psychiatry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Roya SamadiPsychiatry and Behavioral Sciences Research Center, Department of Psychiatry, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Taghi YasamyDepartment of Psychiatry, Shahid Beheshti University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-7204-4713
Mehran ZarghamiDepartment of Psychiatry, School of Medicine AND Psychiatry and Behavioral Sciences Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.ORCID 0000-0002-7027-0992
Farshad FarzadfarNon-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8288-4046
Saeid ShahrazThe Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One in eight adults in Iran is estimated to have major depressive disorder (MDD) - a leading cause of disability in the country. Many remain undiagnosed, and some receive only partial treatment. An estimated 60% of those with MDD were reported to have received no treatment during the past year. In this paper, we have critically reviewed the current health-care structure in the country along with prevailing patterns of health-care service utilization. We have addressed the role of psychiatrists, general practitioners (GPs), psychologists, and other health-care personnel in the treatment and care of patients with MDD, with an emphasis on the quality of service provision. In addition, the strengths and weaknesses of primary healthcare (PHC), the health insurance system, and inpatient care have been discussed. We have paid attention to the contextual issues such as mental health literacy, stigma, and healthcare inequity where relevant. Finally, practical recommendations have been provided to improve the quality of care for patients with MDD in Iran.

Indexed as

Major Depressive DisorderPsychiatryAdultDelivery of Health CareHumansIranPatient Acceptance of Health CareBurdenDepressionHealth equityMood disorderUnmet need

Identifiers

PMID35943010
PMCPMC11904293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.